Financhill
Back

Blueprint Medicines Stock Price Chart

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BPMC is experiencing buying pressure, which is a positive indicator for future bullish movement.

Blueprint Medicines Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 91.9 Sell
20-day SMA: 93.93 Sell
50-day SMA: 92.53 Sell
200-day SMA: 96.72 Sell
8-day EMA: 91.64 Sell
20-day EMA: 92.89 Sell
50-day EMA: 93.08 Sell
200-day EMA: 91.72 Sell

Blueprint Medicines Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.82 Sell
Relative Strength Index (14 RSI): 46.21 Sell
Chaikin Money Flow: 190165 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (91.78 - 96.44) Sell
Bollinger Bands (100): (87.55 - 95.79) Sell

Blueprint Medicines Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for Blueprint Medicines Stock

Is Blueprint Medicines Stock a Buy?

BPMC Technical Analysis vs Fundamental Analysis

Sell
27
Blueprint Medicines (BPMC) is a Sell

Is Blueprint Medicines a Buy or a Sell?

Blueprint Medicines Stock Info

Market Cap:
5.8B
Price in USD:
91.62
Share Volume:
267.9K

Blueprint Medicines 52-Week Range

52-Week High:
121.90
52-Week Low:
72.24
Sell
27
Blueprint Medicines (BPMC) is a Sell

Blueprint Medicines Share Price Forecast

Is Blueprint Medicines Stock a Buy?

  • Blueprint Medicines share price is 91.62 while BPMC 8-day exponential moving average is 91.64, which is a Sell signal.
  • The stock price of BPMC is 91.62 while Blueprint Medicines 20-day EMA is 92.89, which makes it a Sell.
  • Blueprint Medicines 50-day exponential moving average is 93.08 while BPMC share price is 91.62, making it a Sell technically.
  • BPMC stock price is 91.62 and Blueprint Medicines 200-day simple moving average is 91.72, creating a Sell signal.

Fundamental Analysis of Blueprint Medicines

Is Blueprint Medicines a good investment?

  • Analysts estimate an earnings increase this quarter of $0.73 per share, a decrease next quarter of $0.00 per share, an increase this year of $7.18 per share, and an increase next year of $0.57 per share.

Technical Analysis of Blueprint Medicines

Should I short Blueprint Medicines stock?

* Blueprint Medicines stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.